Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Progressive diseases

Hepatic arterial infusion chemotherapy (HAlC) versus sorafenib for hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer (BCLC) B/C: A systematic review and meta-analysis

Zhengqiang Chen, Yaotian Fan, Yuting Luo, Xiwen Ye, Zhen You

published 18 Feb 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Improved drug-screening tests of candidate anti-cancer drugs in patient-derived xenografts through use of numerous measures of tumor growth determined in multiple independent laboratories

Elizabeth Rosenzweig, David E. Axelrod, Derek Gordon

published 18 Jun 2025

Loading metrics information...

Metrics unavailable. Please check back later.

Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry

Adam Irving, Dennis Petrie, Anthony Harris, Laura Fanning, Erica M. Wood, Elizabeth Moore, Cameron Wellard, Neil Waters, Kim Huynh, Bradley Augustson, Gordon Cook, Francesca Gay, Georgia McCaughan, Peter Mollee, Andrew Spencer, Zoe K. McQuilten

published 27 Aug 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Reversal of diabetes by an oral Salmonella-based vaccine in acute and progressive diabetes in NOD mice

Jacob Cobb, Jeffrey Rawson, Nelson Gonzalez, Chris Orr, Fouad Kandeel, Mohamed I. Husseiny

published 23 May 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan

Tatsuya Yamashita, Natsumi Suzuki, Katsuaki Motoyoshi, Wanjun Zhu, Junji Furuse

published 08 Mar 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Short report: Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study

Chen Makranz, Asael Lubotzky, Hai Zemmour, Ruth Shemer, Benjamin Glaser, Jonathan Cohen, Myriam Maoz, Eli Sapir, Marc Wygoda, Tamar Peretz, Noam Weizman, Jon Feldman, Ross A. Abrams, Alexander Lossos, Yuval Dor, Aviad Zick

published 28 Nov 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies

Heather Wilson-Robles, Emma Warry, Tasha Miller, Jill Jarvis, Matthew Matsushita, Pamela Miller, Marielle Herzog, Jean-Valery Turatsinze, Theresa K. Kelly, S. Thomas Butera, Gaetan Michel

published 10 May 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)

Julia González-Rincón, José A. Garcia-Vela, Sagrario Gómez, Belén Fernández-Cuevas, Sara Nova-Gurumeta, Nuria Pérez-Sanz, Miguel Alcoceba, Marcos González, Eduardo Anguita, Javier López-Jiménez, Eva González-Barca, Lucrecia Yáñez, Ernesto Pérez-Persona, Javier de la Serna, Miguel Fernández-Zarzoso, Guillermo Deben, Francisco J. Peñalver, María C. Fernández, Jaime Pérez de Oteyza, M. Ángeles Andreu, M. Ángeles Ruíz-Guinaldo, Raquel Paz-Arias, M. Dolores García-Malo, Valle Recasens, Rosa Collado, Raúl Córdoba, Belén Navarro-Matilla, Margarita Sánchez-Beato, José A. García-Marco

published 10 Sep 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Association between keratoconus disease severity and repeatability in measurements of parameters for the assessment of progressive disease

Ingemar Gustafsson, Anders Bergström, Anna Cardiakides Myers, Anders Ivarsen, Jesper Hjortdal

published 14 Feb 2020

Loading metrics information...

Metrics unavailable. Please check back later.

An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies

Alexandre Perrier, Pierre-Yves Boelle, Yves Chrétien, Joseph Gligorov, Jean-Pierre Lotz, Didier Brault, Eva Comperat, Guillaume Lefèvre, Mathieu Boissan

published 07 Jan 2020

Loading metrics information...

Metrics unavailable. Please check back later.

Mechanisms of acquired resistance to afatinib clarified with liquid biopsy

Tomomi Nakamura, Chiho Nakashima, Kazutoshi Komiya, Kazuki Kitera, Mitsuharu Hirai, Shinya Kimura, Naoko Aragane

published 14 Dec 2018

Loading metrics information...

Metrics unavailable. Please check back later.

The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer

Tatsunori Kiriu, Masatsugu Yamamoto, Tatsuya Nagano, Daisuke Hazama, Reina Sekiya, Masahiro Katsurada, Daisuke Tamura, Motoko Tachihara, Kazuyuki Kobayashi, Yoshihiro Nishimura

published 15 Feb 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Recurrence of Dupuytren’s contracture: A consensus-based definition

Hester J. Kan, Frank W. Verrijp, Steven E. R. Hovius, Christianne A. van Nieuwenhoven, Dupuytren Delphi Group , Ruud W. Selles

published 15 May 2017

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Progressive diseases

You can change these options by clicking profile then "Alerts and Notifications"